wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 1 - 50 of 341.
1 2 3 4 5 7 Next »

Environment/Sustainable Development - Civil Engineering/Traffic Engineering
21.07.2017
"Asphalt has a major downside"
Together with scientists from Empa, ETH Professor Jan Carmeliet studied the latest heatwave last June.
Civil Engineering/Traffic Engineering - Physics/Materials Science
21.07.2017
Cities suffer from higher temperatures
Cities suffer from higher temperatures
June 2017 broke quite a few weather records in Switzerland. Above all the month was extraordinarily hot, the second hottest June on records, peaking in a heat wave between 19 and 23 June. Cities heat up even more than the surrounding regions, an effect known as urban heat islands.
Chemistry - Physics/Materials Science
20.07.2017
3D imaging of surface chemistry in confinement
3D imaging of surface chemistry in confinement
EPFL researchers have developed an optical imaging tool to visualize surface chemistry in real time. They imaged the interfacial chemistry in the microscopically confined geometry of a simple glass micro-capillary. The glass is covered with hydroxyl (-OH) groups that can lose a proton - a much-studied chemical reaction that is important in geology, chemistry and technology.
Life Sciences - Medicine/Pharmacology
20.07.2017
Innate Reaction of Hematopoietic Stem Cells to Severe Infections
If severe infections result, the body must form more white blood cells to fight off infectious agents. Hematopoietic stem cells in the bone marrow are responsible for their production. These cells, which renew themselves throughout a person's lifetime, form all cells of the hematopoietic system.
Environment/Sustainable Development
20.07.2017
Swiss Forestry Statistics 2016 - Declining timber harvest hits ten-year low
Neuchâtel, 20.07.2017 - (FSO) - In 2016 the Swiss timber harvest continued its decline.
Medicine/Pharmacology - Computer Science/Telecom
19.07.2017
Smart walk assist improves rehabilitation
A mobile harness suspended from the ceiling is now equipped with intelligent motion analysis for tailored walking rehabilitation in people suffering from spinal cord injury, stroke and other neurological disorders affecting gait.
Computer Science/Telecom - Medicine/Pharmacology
19.07.2017
"It’s always a compromise"
Digitalisation simplifies many aspects of our everyday life, but it also creates new risks. Srdjan Capkun, Professor for Information Security, explains how to find the right balance between convenience and security.
Chemistry - Physics/Materials Science
19.07.2017
A uranium-based compound improves manufacturing of nitrogen products
A uranium-based compound improves manufacturing of nitrogen products
EPFL scientists have developed a uranium-based complex that can allow nitrogen fixation reactions to take place in ambient conditions.
Philosophy - Social Sciences
18.07.2017
"Don’t rely on your holidays to make you happy"
Travel and happiness have a complicated relationship - even the Stoics were aware of this. An interview with philosopher Michael Hampe on the opportunities and risks that come with travelling.
Social Sciences - Life Sciences
18.07.2017
Low-dose diazepam can increase social competitiveness
Low-dose diazepam can increase social competitiveness
EPFL scientists have discovered how low-dose anxiolytics increase the social competitiveness of high-anxious individuals by boosting the energy output of mitochondria in an area of the mammalian brain that controls motivation and reward. Psychologists speak of anxiety in two forms: ‘state' anxiety, which refers to anxiety arising from a particular situation; and ‘trait' anxiety, which refers to anxiety as part of a person's overall personality.
Business/Economics - Medicine/Pharmacology
18.07.2017
Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
Net sales in line with prior year (0% cc , -2% USD), as growth drivers offset Gleevec/Glivec Gx impact: Cosentyx (USD 490 million, +90% cc) continues strong growth in all three indications Entresto (U
Medicine/Pharmacology - Life Sciences
17.07.2017
Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
Roche's OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia Second approval after the US for OCREVUS as the first and only approved treatment for peop
Civil Engineering/Traffic Engineering
17.07.2017
From rail to sky in a Clip-Air capsule
From rail to sky in a Clip-Air capsule
Summer series - students works. For his Master's project, Martin Ellwanger worked on the capsules that are an integral part of the Clip-Air modular airplane.
Medicine/Pharmacology
14.07.2017
Novartis confirms 5 year data for first and only fully-human IL-17A inhibitor Cosentyx reinforcing sustained efficacy and safety profile in psoriasis
Novartis confirms 5 year data for first and only fully-human IL-17A inhibitor Cosentyx reinforcing sustained efficacy and safety profile in psoriasis 5 year data from long-term Phase III extension study demonstrate sustained efficacy and safety of Cosentyx in patients with moderate-to-severe plaque psoriasis   Data planned to be presented at a key medical congress in the second half of 2017.
Physics/Materials Science
14.07.2017
Coupling a Nano-trumpet With a Quantum Dot Enables Precise Position Determination
Coupling a Nano-trumpet With a Quantum Dot Enables Precise Position Determination
Scientists from the Swiss Nanoscience Institute and the University of Basel have succeeded in coupling an extremely small quantum dot with 1,000 times larger trumpet-shaped nanowire.
Medicine/Pharmacology - Life Sciences
13.07.2017
Novartis CAR-T cell therapy CTL019 unanimously (10-0) recommended for approval by FDA advisory committee to treat pediatric, young adult r/r B-cell ALL
Novartis CAR-T cell therapy CTL019 unanimously (10-0) recommended for approval by FDA advisory committee to treat pediatric, young adult r/r B-cell ALL Recommendation based on review of CTL019 r/r B
Environment/Sustainable Development
11.07.2017
Most comprehensive database on past global changes is online
Most comprehensive database on past global changes is online
Media releases, information for representatives of the media Media Relations (E) Climate scientists will now be able to more accurately study the pattern and causes of global surface temperature chan
Administration/Government
11.07.2017
Use-inspired basic research: external report recommends targeted adjustments
Use-inspired basic research: external report recommends targeted adjustments
The Swiss National Science Foundation (SNSF) commissioned an external evaluation of its funding category "use-inspired basic research" last year. Based on the evaluators' recommendations, it has now decided to introduce targeted changes in its processes. Based on a mandate from the federal government, the Swiss National Science Foundation promotes scientific research; the focus is on basic research.
Physics/Materials Science - Chemistry
11.07.2017
From Bangalore via Cambridge to Zurich
From Bangalore via Cambridge to Zurich
Priyank Kumar became a materials scientist mainly by chance. His enthusiasm for complex simulations of material properties took him from India to MIT, and then to ETH.
Medicine/Pharmacology - Administration/Government
10.07.2017
Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine
Positive phase III results for Roche's emicizumab in haemophilia A published in The New England Journal of Medicine HAVEN 1 showed emicizumab reduced bleed rate by 87% compared with on-demand bypassing agents All 12 secondary endpoints in HAVEN 1 were positive, including an intra-patient comparison that showed emicizumab reduced bleed rate by 79% compared to prior prophylactic bypassing agents Data from HAVEN 1 in adults and adolescents and inte
Life Sciences
10.07.2017
Synapses in the Brain Mirror the Structure of the Visual World
Synapses in the Brain Mirror the Structure of the Visual World
The research team of Prof. Sonja Hofer at the Biozentrum, University of Basel, has discovered why our brain might be so good at perceiving edges and contours. Neurons that respond to different parts of elongated edges are connected and thus exchange information. This can make it easier for the brain to identify contours of objects.
Mechanical Engineering/Mechanics - Mathematics
10.07.2017
Fine particles come into greater focus
Fine particles come into greater focus
An EPFL study has deepened our understanding of the fine particles produced by adhesive wear. This breakthrough could lead to cost savings and environmental benefits. Adhesive wear occurs when two surfaces - such as a brake pad and a wheel's disc, or a car tire and the road - rub against each other.
Computer Science/Telecom - Life Sciences
07.07.2017
Eight professors appointed at ETH Zurich
Eight professors appointed at ETH Zurich
The ETH Board appointed new professors at ETH Zurich as part of its meeting of 5/6 July 2017, in accordance with the application submitted by ETH Zurich President Lino Guzzella.
Physics/Materials Science - Chemistry
07.07.2017
Research experience from California benefits Swiss X-ray free-electron laser SwissFEL
Research experience from California benefits Swiss X-ray free-electron laser SwissFEL
Two scientists who have studied superconductivity and magnetic molecular switching at the Californian X-ray laser LCLS have relocated to PSI. Here, they will contribute to the development of the SwissFEL. It's the camera that allows researchers to make extremely rapid processes visible: the X-ray free-electron laser.
Physics/Materials Science - Chemistry
07.07.2017
X-ray Lasers Show Mechanisms behind Superconductors and Magnetic Switching
X-ray Lasers Show Mechanisms behind Superconductors and Magnetic Switching
Research experience from California's X-ray free-electron laser benefits SwissFEL It's the camera that allows researchers to make extremely rapid processes visible: the X-ray free-electron laser. Currently, however, only three sites worldwide—in the US, Japan and South Korea—have facilities capable of carrying out such measurements.
Administration/Government - Careers/Employment
06.07.2017
Ten years of the European Research Council: positive record from Swiss perspective
Bern, 06.07.2017 - An event was held in Geneva on 6 July to mark the tenth anniversary of the European Research Council (ERC).
Medicine/Pharmacology
06.07.2017
Novartis receives approval in the EU for Cosentyx label update, includes long term superiority data versus Stelara in psoriasis
Label update includes 52 week data from CLEAR study demonstrating long-term superiority of Cosentyx versus Stelara in psoriasis ,   Update also includes use of Cosentyx in moderate-to-severe scalp ps
Computer Science/Telecom - Mathematics
04.07.2017
On fast track at ETH
On fast track at ETH
At the age of 29, Professor of Computer Science Mohsen Ghaffari is one of the youngest professors at ETH Zurich.
Life Sciences
04.07.2017
Praying Mantises Hunt Down Birds Worldwide
Praying Mantises Hunt Down Birds Worldwide
A study by zoologists from Switzerland and the US shows: praying mantises all over the globe also include birds in their diet. The Wilson Journal of Ornithology has just published the results. Praying mantises are carnivorous insects with powerful raptorial front legs that usually depend on arthropods such as insects or spiders as their primary prey.
Chemistry - Careers/Employment
03.07.2017
Meeting Nobel Laureates
Meeting Nobel Laureates
ETH Zurich's Thomas Gianetti meets up with the world's most promising Young Scientists at the Lindau Nobel Laureate Meeting.
Environment/Sustainable Development
01.07.2017
«We have to talk about what the future
«We have to talk about what the future
In May 2016, Patrick Wäger took over the helm at Empa's Technology and Society lab. Closing material cycles and performing life cycle and technology assessments are just some of the topics that now come under his dominion.
Computer Science/Telecom - Microtechnics/Electroengineering
29.06.2017
Building with robots and 3D printers
Building with robots and 3D printers
At the Empa and Eawag NEST building in Dübendorf, eight ETH Zurich professors are collaborating with business partners to build the three-storey DFAB HOUSE.
Chemistry - Physics/Materials Science
29.06.2017
Fuel and chemicals from plant waste
Fuel and chemicals from plant waste
From the inexhaustible raw material lignin, which as a constituent of many plants accumulates in great quantities, fuels and other important substances could in theory be extracted for industry - so far, though, it can't be done efficiently enough. Researchers at the Paul Scherrer Institute PSI and ETH Zurich have now found a method for identifying heretofore unseen intermediate products of the catalytic reactions used for this conversion.
Medicine/Pharmacology - Life Sciences
29.06.2017
Novartis receives EU approval for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer (NSCLC)
In ALK-positive advanced NSCLC patients, Zykadia demonstrated superior median progression-free survival (PFS) compared to SOC chemotherapy with maintenance   Zykadia benefit was also seen in patients
Life Sciences - Medicine/Pharmacology
29.06.2017
Designed Proteins to Treat Muscular Dystrophy
Designed Proteins to Treat Muscular Dystrophy
The cell scaffolding holds muscle fibers together and protects them from damage. Individuals who suffer from muscular dystrophy often lack essential components in this cell scaffold. As a result, their muscles lack strength and become progressively weaker. The research team of Prof. Markus Rüegg at the Biozentrum, University of Basel, has now designed two proteins that stabilize the cell scaffolding link it to the muscle fiber and thereby restore muscle structure and function.
Medicine/Pharmacology - Life Sciences
28.06.2017
The gene behind follicular lymphoma
The gene behind follicular lymphoma
EPFL scientists have discovered an important gene whose loss lies behind follicular lymphoma, an incurable cancer. Follicular lymphoma is an incurable cancer that affects over 200,000 people worldwide every year. A form of non-Hodgkin lymphoma, follicular lymphoma develops when the body starts making abnormal B-cells, which are white blood cells that in normal conditions fight infections.
Medicine/Pharmacology - Life Sciences
27.06.2017
Sandoz receives approval in Europe for Erelzi (biosimilar etanercept) to treat multiple inflammatory diseases
European Commission approves Sandoz Erelzi to treat immunological diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis Approval of Erelzi provides more treatment options for heal
Computer Science/Telecom - Business/Economics
27.06.2017
More security in cyberspace
More security in cyberspace
At yesterday's Cyber Risks Summit at ETH Zurich, international experts discussed and presented the latest scientific and technological approaches for effectively protecting society from the dangers of cyberspace.
Medicine/Pharmacology - Administration/Government
27.06.2017
Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF)
Fewer pills, more flexibility in dosing: Roche's new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF) New immediate-release tablet formulation of
Physics/Materials Science - Environment/Sustainable Development
26.06.2017
Microplastics from the washing machine
Microplastics from the washing machine
Even before the UN Ocean Conference in early June, we already knew about the disastrous ways in which plastic affects the world's oceans. Billions of pieces of plastic are floating in the oceans. Their effects are also sufficiently well-known: marine animals swallow them or get tangled up in them, which causes them to die in agony.
Physics/Materials Science - Astronomy
26.06.2017
A gravity researcher in search of weightlessness
A gravity researcher in search of weightlessness
Lavinia Heisenberg is a theoretical physicist. She is reluctant to accept that General Relativity can be used to describe the universe only on the assumption of exotic materials and energy sources.
Civil Engineering/Traffic Engineering
26.06.2017
Medicine/Pharmacology - Life Sciences
26.06.2017
Roche’s emicizumab showed positive results in phase III studies (HAVEN 1 and HAVEN 2) in haemophilia A with inhibitors
Roche's emicizumab showed positive results in phase III studies (HAVEN 1 and HAVEN 2) in haemophilia A with inhibitors Emicizumab showed substantial and clinically meaningful reduction in bleeds across two pivotal studies Data from HAVEN 1 in adults and adolescents and interim data from HAVEN 2 in children to be presented at the 26th International Society on Thrombosis and Haemostasis (ISTH) Meeting Roche today announced positive data from the p
Medicine/Pharmacology - Life Sciences
23.06.2017
NEJM publishes full analysis of Rydapt (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
Significant overall survival benefit observed for FLT3+ AML patients consistent across FLT3 mutation subgroups, including ITD and TKD Detailed data show Rydapt plus standard chemotherapy improved eve
Medicine/Pharmacology - Life Sciences
23.06.2017
Novartis Kisqali (ribociclib) receives positive CHMP opinion as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor
Novartis Kisqali (ribociclib) receives positive CHMP opinion as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor CHMP opinio
Medicine/Pharmacology - Life Sciences
23.06.2017
Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL
83% of patients achieved complete remission (CR) or CR with incomplete blood count recovery within 3 months of treatment with CTL019; consistent with interim ELIANA data   Data evaluating 63 patients demonstrate relapse-free survival and probability of survival in a majority of patients at six months   Advances in CTL019 and ELIANA result from global CAR-T cell therapy collaboration with the University of Pennsylvania   CTL019 is manufactured us
Medicine/Pharmacology - Chemistry
23.06.2017
Novartis data shows half of eligible Ph+ CML-CP patients remain in Treatment-free Remission nearly two years after stopping Tasigna
New 96-week data support durability and safety of Treatment-free Remission (TFR) in Ph+ CML-CP patients who stop taking Tasigna [1,2] More than 90% of Ph+ CML-CP patients in ENESTfreedom and ENESTop who stopped Tasigna and were in TFR at 48 weeks remained in TFR at 96 weeks [1,2] 48-week data from same trials recently added to Tasigna SmPC following EC approval; discussions with other regulatory authorities are underway worldwide - Novartis toda
Medicine/Pharmacology - Life Sciences
23.06.2017
Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain patients with high-risk chronic lymphocytic leukaemia and its potential in other hard-to-treat blood cancers
Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain patients with high-risk chronic lymphocytic leukaemia and its potential in other hard-to-treat blood cancers First in class BCL2-specific oral inhibitor represents a potential new way of treating different blood cancers Efficacy and tolerability confirmed in high-risk patients with relapsed or refractory chronic lymphocytic leukaemia, including those with 17p chromosomal de
Medicine/Pharmacology - Physics/Materials Science
23.06.2017
Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma
Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma Longer follow-up showed sustained benefit in progression-free survival of Gazyva/Gazyvaro-based treatment over MabThera/Rituxan-based treatment regardless of chemotherapy regimens People with follicular lymphoma who received Gazyva/Gazyvaro-based treatment reported improvement in health-related qualit
1 2 3 4 5 7 Next »